Comparable stake leader
David P. Perry
SEC ownership of Better Therapeutics, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001832415.
Disclosed value leader
David P. Perry
Comparable rows
0/15
Latest evidence
09 Feb 2024
- Parsed ownership sources
-
3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
David P. Perry
Ranking: Comparable ownership first, then disclosed value
- Latest parsed ownership date
-
09 Feb 2024
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001832415
- Issuer location
- San Francisco, CA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
1 signal
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Better Therapeutics, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
David P. Perry
Disclosed value leader
David P. Perry
Comparable rows
0/15
Latest evidence
09 Feb 2024
3/4/5
Highest disclosed value: $3,695,296
15 rows are not safely comparable across share classes.
Showing 1-8 of 15 holder rows.
Quick read
David P. Perry has the largest disclosed position value at $3.7M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens David P. Perry's linked filing trail.
Disclosed position value
Top 5
David P. Perry
$3.7M
Georgianna Maule-Ffinch 2015 Trust
$617.8K
Kevin J. Appelbaum
$410K
Mr. Geoffrey Parker
$184.4K
Andrew J. Armanino
$126.7K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-8 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| David P. Perry |
3/4/5
Executive Chairman, Director, 10%+ Owner
|
—
class O/S missing
|
$3,695,296
19,397,877 shares
|
— | 09 Feb 2024 |
| Georgianna Maule-Ffinch 2015 Trust |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$617,818
3,636,364 shares
|
— | 10 Apr 2023 |
| Kevin J. Appelbaum |
3/4/5
Chief Executive Officer, Director, 10%+ Owner
|
—
mixed-class rows
|
$409,964
2,647,969 shares
mixed-class rows
|
— | 31 Mar 2022 |
| Mr. Geoffrey Parker |
3/4/5
Director
|
—
class O/S missing
|
$184,365
1,085,138 shares
|
— | 18 Dec 2023 |
| Andrew J. Armanino |
3/4/5
Director
|
—
class O/S missing
|
$126,653
745,452 shares
|
— | 18 Dec 2023 |
| Frank Karbe |
3/4/5
Chief Executive Officer, Director
|
—
class O/S missing
|
$89,455
526,516 shares
|
— | 18 Dec 2023 |
| Mark A. Berman |
3/4/5
Chief Medical Officer
|
—
class O/S missing
|
$76,139
448,140 shares
|
— | 18 Dec 2023 |
| Kristin Wynholds |
3/4/5
Chief Product Officer
|
—
mixed-class rows
|
$38,335
327,081 shares
mixed-class rows
|
— | 18 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 13 Sep 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-15 of 15 reporting-owner rows connected to Better Therapeutics, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
15
Largest Forms 3/4/5 holder
David P. Perry
Net 12M change
$0
Latest report
09 Feb 2024
Recent insider transactions for Better Therapeutics, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* marks a reported price that did not pass the local price check.